Heather Sweet

485 total citations
12 papers, 381 citations indexed

About

Heather Sweet is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Heather Sweet has authored 12 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Immunology. Recurrent topics in Heather Sweet's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Biosimilars and Bioanalytical Methods (5 papers) and Protein purification and stability (3 papers). Heather Sweet is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Biosimilars and Bioanalytical Methods (5 papers) and Protein purification and stability (3 papers). Heather Sweet collaborates with scholars based in United States and Canada. Heather Sweet's co-authors include Ian N. Foltz, Wei Yan, Kannan Gunasekaran, Kathy Manchulenko, Anne Woodward, Min Shen, Teresa L. Born, Marc W. Retter, Carla Forte and Michael Wittekind and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Gastroenterology.

In The Last Decade

Heather Sweet

12 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heather Sweet United States 7 266 254 134 88 30 12 381
Bhaswati Barat United States 10 223 0.8× 200 0.8× 98 0.7× 137 1.6× 42 1.4× 17 426
Roland Stork Germany 6 306 1.2× 319 1.3× 108 0.8× 120 1.4× 20 0.7× 6 446
Jochem Gokemeijer United States 9 275 1.0× 258 1.0× 176 1.3× 138 1.6× 20 0.7× 18 460
Mary McFarlane United Kingdom 4 190 0.7× 187 0.7× 71 0.5× 51 0.6× 37 1.2× 6 334
Meike Hutt Germany 10 219 0.8× 171 0.7× 91 0.7× 112 1.3× 15 0.5× 16 338
Melody Sauerborn Netherlands 9 307 1.2× 265 1.0× 184 1.4× 40 0.5× 26 0.9× 10 441
Christian Spick Switzerland 6 298 1.1× 328 1.3× 176 1.3× 113 1.3× 29 1.0× 9 489
Christelle Souriau France 7 363 1.4× 355 1.4× 67 0.5× 85 1.0× 33 1.1× 9 495
Whitney Shatz-Binder United States 13 388 1.5× 354 1.4× 113 0.8× 76 0.9× 38 1.3× 21 592
Anna Park United States 10 320 1.2× 392 1.5× 101 0.8× 166 1.9× 21 0.7× 17 514

Countries citing papers authored by Heather Sweet

Since Specialization
Citations

This map shows the geographic impact of Heather Sweet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather Sweet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather Sweet more than expected).

Fields of papers citing papers by Heather Sweet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather Sweet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather Sweet. The network helps show where Heather Sweet may publish in the future.

Co-authorship network of co-authors of Heather Sweet

This figure shows the co-authorship network connecting the top 25 collaborators of Heather Sweet. A scholar is included among the top collaborators of Heather Sweet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather Sweet. Heather Sweet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Seo, Neung‐Seon, Zhe Huang, Scott Kuhns, et al.. (2020). Analytical and functional similarity of biosimilar ABP 798 with rituximab reference product. Biologicals. 68. 79–91. 13 indexed citations
2.
Wang, Wei, Heather Sweet, Raffi Manoukian, et al.. (2019). Functional and Nonclinical Similarity of ABP 980, a Biosimilar of Trastuzumab. Pharmaceutical Research. 36(12). 177–177. 15 indexed citations
3.
Halder, Smita, Waliul I. Khan, Scott Kuhns, et al.. (2019). P071 Supporting extrapolation of indications for ABP 501, the first adalimumab biosimilar: focus on Crohn’s disease. Journal of Crohn s and Colitis. 13(Supplement_1). S121–S121. 1 indexed citations
4.
McBride, Helen J., et al.. (2017). Functional Similarity of Proposed Biosimilar ABP 798 with Rituximab. Blood. 130. 5001–5001. 1 indexed citations
5.
McBride, Helen J., Scott Kuhns, Ian N. Foltz, Heather Sweet, & Primal Kaur. (2017). ABP 501: Matching the Critical Functions of Adalimumab. Gastroenterology. 152(5). S765–S765. 2 indexed citations
6.
Liu, Zhi, Kannan Gunasekaran, Wei Wang, et al.. (2013). Asymmetrical Fc Engineering Greatly Enhances Antibody-dependent Cellular Cytotoxicity (ADCC) Effector Function and Stability of the Modified Antibodies. Journal of Biological Chemistry. 289(6). 3571–3590. 58 indexed citations
7.
Coxon, Angela, Stephen A. Kaufman, Man Xu, et al.. (2012). Antitumor activity of motesanib alone and in combination with cisplatin or docetaxel in multiple human non–small-cell lung cancer xenograft models. Molecular Cancer. 11(1). 70–70. 19 indexed citations
8.
Gunasekaran, Kannan, Min Shen, Carla Forte, et al.. (2010). Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering Effects. Journal of Biological Chemistry. 285(25). 19637–19646. 213 indexed citations
9.
Kaufman, Stephen A., Man Xu, Hongyu Wang, et al.. (2010). Abstract 1380: Antitumor activity of motesanib alone and in combination with chemotherapy in xenograft models of human non-small cell lung cancer. Cancer Research. 70(8_Supplement). 1380–1380. 1 indexed citations
10.
Shan, Siqing, et al.. (2005). Preferential extravasation and accumulation of liposomal vincristine in tumor comparing to normal tissue enhances antitumor activity. Cancer Chemotherapy and Pharmacology. 58(2). 245–255. 16 indexed citations
11.
Semple, Sean C., Zheng Yuan, Marianne Eisenhardt, et al.. (2004). 605 Encapsulation of vinorelbine in sphingomyelin/cholesterol liposomes enhances the tumor exposure and antitumor activity of vinorelbine in human mammary and non-small cell lung cancer solid tumor models. European Journal of Cancer Supplements. 2(8). 183–183. 1 indexed citations
12.
Anthony, Lawrence S.D., et al.. (1999). Priming of CD8+ CTL effector cells in mice by immunization with a stress protein–influenza virus nucleoprotein fusion molecule. Vaccine. 17(4). 373–383. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bhaswati Barat Breakdown of academic impact, for papers by Roland Stork Breakdown of academic impact, for papers by Jochem Gokemeijer Breakdown of academic impact, for papers by Mary McFarlane Breakdown of academic impact, for papers by Meike Hutt Breakdown of academic impact, for papers by Melody Sauerborn Breakdown of academic impact, for papers by Christian Spick Breakdown of academic impact, for papers by Christelle Souriau Breakdown of academic impact, for papers by Whitney Shatz-Binder Breakdown of academic impact, for papers by Anna Park
Rankless by CCL
2026